BioRem Inc. (TSXV:BRM)

BioRem Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.5	5.21	2.29	3.78	4.47
Cash & Short-Term Investments	11.5	5.21	2.29	3.78	4.47
Cash Growth	120.70%	127.46%	-39.29%	-15.57%	-49.59%
Accounts Receivable	15.2	14.87	14.11	12.24	10.13
Inventory	1.37	2.9	0.9	0.89	0.9
Other Current Assets	2.48	1.54	2.33	0.87	0.66
Total Current Assets	30.55	24.52	19.63	17.77	16.17
Net Property, Plant & Equipment	1.83	2.02	1.99	1.02	1.15
Other Long-Term Assets	1.2	1.97	2.45	1.94	1.86
Total Assets	33.58	28.51	24.08	20.73	19.17
Accounts Payable	7.95	4.02	6.14	4.71	5.07
Accrued Expenses	1.84	2.44	2.13	2.66	2.51
Short-Term Debt	0.59	0.57	0.55	1.3	1.51
Current Portion of Leases	0.08	0.12	0.18	0.16	0.19
Unearned Revenue	4.59	6.37	4.31	2.57	3.02
Other Current Liabilities	1.44	1.5	0.6	1.52	0.94
Total Current Liabilities	16.49	15.02	13.89	12.92	13.23
Long-Term Debt	1.26	1.86	2.43	2.98	3.5
Long-Term Leases	0.89	1.01	1.03	0.31	0.47
Total Long-Term Liabilities	2.16	2.87	3.46	3.29	3.97
Total Liabilities	18.65	17.89	17.36	16.21	17.2
Common Stock	5.2	5.2	5	4.91	4.91
Additional Paid-in Capital	2.53	2.47	2.37	2.26	2.17
Accumulated Other Comprehensive Income	1.34	1.83	1.27	1.45	0.6
Retained Earnings	5.86	1.13	-1.92	-4.1	-5.71
Shareholders' Equity	14.93	10.63	6.72	4.52	1.96
Total Liabilities & Equity	33.58	28.51	24.08	20.73	19.17
Total Debt	2.83	3.56	4.19	4.75	5.67
Net Cash (Debt)	8.67	1.66	-1.89	-0.97	-1.19
Net Cash Growth	423.67%	-	-	-	-
Net Cash Per Share	0.47	0.09	-0.11	-0.06	-0.03
Book Value	14.93	10.63	6.72	4.52	1.96
Book Value Per Share	0.80	0.57	0.39	0.26	0.05
Tangible Book Value	14.93	10.63	6.72	4.52	1.96
Tangible Book Value Per Share	0.80	0.57	0.39	0.26	0.05

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.